Inventor · disambiguated record
Martin Glennie
Also filed as: GLENNIE MARTIN · GLENNIE MARTIN J · GLENNIE MARTIN JOHN
12 granted patents·9 pending applications·150 citations·filing 2001–2022
90Inventor score
Top patents by PatentIndex Score
21 records- 0192US9926374B2Human immune therapies using a CD27 agonist in combination with another immune agonist to treat cancerUNIV SOUTHAMPTON·Filed 2015·Granted Mar 27, 2018·13 cites·12 claims
- 0292US8481029B2Human immune therapies using a CD27 agonist alone or in combination with other immune modulatorsGLENNIE MARTIN JOHN·Filed 2007·Granted Jul 9, 2013·50 cites·18 claims
- 0391US9248183B2Human immune therapies using a CD27 agonist alone or in combination with other immune modulatorsUNIV SOUTHAMPTON·Filed 2013·Granted Feb 2, 2016·17 cites·17 claims
- 0491US7850962B2Human monoclonal antibodies against CD20GENMAB AS·Filed 2005·Granted Dec 14, 2010·27 cites·49 claims
- 0589US8529902B2Human monoclonal antibodies against CD20TEELING JESSICA·Filed 2003·Granted Sep 10, 2013·36 cites·5 claims
- 0685US11623005B2Combined use of FcγRIIb (CD32B) and CD20 specific antibodiesUNIV SOUTHAMPTON·Filed 2019·Granted Apr 11, 2023·3 cites·5 claims
- 0773US11447549B2Combination of a Treg depleting anti-4-1BB antibody and anti-PD1 antibodyBIOINVENT INT AB·Filed 2018·Granted Sep 20, 2022·1 cites·14 claims
- 0873US11001638B2Immunomodulatory antibodiesCANCER RESEARCH TECH LTD·Filed 2016·Granted May 11, 2021·1 cites·4 claims
- 0970US2021346498A1Combined use of fc gamma riib (cd32b) and cd20 specific antibodiesUNIV SOUTHAMPTON·Filed 2021·Application pending·0 cites
- 1068US2020317799A1Human Monoclonal Antibodies Against CD20GENMAB AS·Filed 2019·Application pending·0 cites
- 1165US10525129B2Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodiesCRAGG MARK·Filed 2011·Granted Jan 7, 2020·2 cites·32 claims
- 1265US2020247898A1Human immune therapies using a cd27 agonist alone or in combination with other immune modulatorsUNIV SOUTHAMPTON·Filed 2020·Application pending·0 cites
- 1364US11780929B2Immunomodulatory antibodiesCANCER RESEARCH TECH LTD·Filed 2021·Granted Oct 10, 2023·0 cites·3 claims
- 1463US2023058227A1Novel antibodies and combined use of a treg depleting antibody and an immunostimulatory antibodyBIOINVENT INT AB·Filed 2022·Application pending·0 cites
- 1560US2018273631A1Human immune therapies using a cd27 agonist in combination with another immune agonist to treat cancerUNIV SOUTHAMPTON·Filed 2018·Application pending·0 cites
- 1656US2009074711A1Human therapies using chimeric agonistic anti-human cd40 antibodyUNIV SOUTHAMPTON·Filed 2007·Application pending·0 cites
- 1755US2014093454A1Human Monoclonal Antibodies Against CD20GENMAB AS·Filed 2013·Application pending·0 cites
- 1854US2021347907A1Modified antibodies containing modified igg2 domains which elicit agonist or antagonistic properties and use thereofCANCER RESEARCH TECH LTD·Filed 2021·Application pending·0 cites
- 1944US11059898B2Modified antibodies containing modified IGG2 domains which elicit agonist or antagonistic properties and use thereofUNIV SOUTHAMPTON·Filed 2015·Granted Jul 13, 2021·0 cites·8 claims
- 2044US2004047873A1Materials and methods relating to the increase in protein activityFiled 2001·Application pending·0 cites
- 2141US12325754B2Cancer and B-cell related disease therapyUNIV SOUTHAMPTON·Filed 2017·Granted Jun 10, 2025·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Martin Glennie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →